Brain volume loss in individuals over time: Source of variance and limits of detectability
Background: Brain volume loss measured from magnetic resonance imaging (MRI) is a marker of neurodegeneration and predictor of disability progression in MS, and is commonly used to assess drug efficacy at the group level in clinical trials. Whether measures of brain volume loss could be useful to he...
Main Authors: | Sridar Narayanan, Kunio Nakamura, Vladimir S. Fonov, Josefina Maranzano, Zografos Caramanos, Paul S. Giacomini, D. Louis Collins, Douglas L. Arnold |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | NeuroImage |
Online Access: | http://www.sciencedirect.com/science/article/pii/S105381192030224X |
Similar Items
-
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis
by: Kunio Nakamura, et al.
Published: (2014-01-01) -
Delineation of cortical pathology in multiple sclerosis using multi-surface magnetization transfer ratio imaging
by: David A. Rudko, et al.
Published: (2016-01-01) -
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies
by: Kunio Nakamura, et al.
Published: (2014-01-01) -
Non-local means inpainting of MS lesions in longitudinal image processing
by: Nicolas eGuizard, et al.
Published: (2015-12-01) -
Improving the SIENA performance using BEaST brain extraction.
by: Kunio Nakamura, et al.
Published: (2018-01-01)